Answers are grounded in this paper and cite their sources.
There is a need for parenteral opioid analgesics with longer durations of action. Suspensions of nalbuphine were formulated by buffering the HCI salt to pH 9-9.2 in the presence of the commonly used suspending agents, methylcellulose, sodium carboxymethylcellulose, and PEG. Each of these suspensions prolonged nalbuphine release, relative to a nalbuphine HCI solution, after intramuscular administration to rats. Peak plasma concentrations were lower, and the half-life was increased more than 2-fold. The methylcellulose suspension had the smallest particle size and gave the highest plasma nalbuphine concentrations. This was also evaluated in dogs, and as in rats, the half-life was approximately doubled. These suspensions can be lyophilized and readily resuspended, and do not appear to be irritating. This is a simple, practical approach to a prolonged release injectable.
No takes yet. Share an insight, caveat, or question.
Hussain et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: